Process Robustness for Complex Drug Delivery Systems

During a routine batch production of an innovative drug delivery system, quality control (QC) analysts noticed an elevated rate of out-of-specification (OOS) results for a critical quality attribute (CQA). Specifically,…

Process Robustness for Complex Drug Delivery Systems

Enhancing Process Robustness in Complex Drug Delivery Systems In the highly regulated pharmaceutical manufacturing space, the ability to ensure process robustness at scale is critical, especially for complex drug delivery…

Process Robustness for Global Manufacturing Networks

Enhancing Process Robustness Across Global Manufacturing Networks In the world of pharmaceutical manufacturing, maintaining process robustness during scale-up and throughout production is crucial for compliance with regulatory standards and ensuring…

Process Robustness for Global Manufacturing Networks

Improving Process Robustness Across Global Manufacturing Networks In a rapidly evolving pharmaceutical landscape, ensuring process robustness at scale is paramount. Companies are confronted with frequent challenges arising from variability inherent…

How to Prevent Robustness Loss During Equipment Change

Strategies to Maintain Equipment Change Integrity for Robust Process Management In the highly regulated environment of pharmaceutical manufacturing, loss of process robustness during equipment changes can lead to significant issues,…

Process Robustness Review Checklist for QA Approval

Recognizing the early signs of process robustness issues is critical for effective intervention. Symptoms may present as variations in product quality, inconsistencies during batch production, or unexpected deviations in critical…

Process Robustness Lessons from PPQ Failures

The initial signal of a robustness issue emerged during an internal audit, where discrepancies in yield and purity levels were observed across batches that were supposed to follow a well-established…

Process Robustness Lessons from PPQ Failures

The first indicator of failure in the PPQ phase was an unexpected increase in the number of out-of-specification (OOS) results during critical quality attribute (CQA) testing. These OOS results primarily…